Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines

  • Jiang S
  • Li R
  • Du L
 et al. 
  • 35


    Mendeley users who have this article in their library.
  • 14


    Citations of this article.


Seasonal influenza epidemics and influenza pandemics caused by influenza A virus (IAV) has resulted in millions of deaths in the world. The development of anti-IAV vaccines and therapeutics is urgently needed for prevention and treatment of IAV infection and for controlling future influenza pandemics. Hemagglutinin (HA) of IAV plays a critical role in viral binding, fusion and entry, and contains the major neutralizing epitopes. Therefore, HA is an attractive target for developing anti-IAV drugs and vaccines. Here we have reviewed the recent progress in study of conformational changes of HA during viral fusion process and development of HA-based antiviral therapeutics and vaccines.

Author-supplied keywords

  • antiviral drugs
  • hemagglutinin
  • influenza A virus
  • vaccines
  • viral entry

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Shibo Jiang

  • Runming Li

  • Lanying Du

  • Shuwen Liu

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free